PT

Pragya Tiwari

Active Director Director DIN 09543953
DIN 09543953 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Pragya Tiwari

Data last updated:

Pragya Tiwari is a Director at Madewell Pharma Private Limited (since 2022). The company operates in Chemicals. Madewell Pharma Private Limited reported revenue of ₹9.1 Lakh (FY 2025).

DIN 09543953
Primary Designation Director
Industry Chemicals
First Appointment 28 Mar 2022
Oldest Company Age 5 yrs
Largest company Madewell Pharma Private Limited · ₹9.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Madewell Pharma Private Limited U24230UP2021PTC152470
Director28 Mar 20222021₹9.1 Lakh (FY 2025)Active

Board colleagues of Pragya Tiwari

NameDINCompanyDesignation
Minhaj Tahir09543924Madewell Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madewell Pharma Private Limited
Premium access

Shareholding and investment profile for Pragya Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pragya Tiwari

Pragya Tiwari currently holds 1 directorship: Madewell Pharma Private Limited (Director, since 28 Mar 2022, revenue ₹9.1 Lakh (FY 2025)).

Pragya Tiwari was first appointed on 28 Mar 2022 as Director at Madewell Pharma Private Limited.

The current boards of Pragya Tiwari's companies include Minhaj Tahir (Madewell Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available